kuldev singh, md, phd
TRANSCRIPT
Spotlight on Pressure Reduction: Market Overview
Kuldev Singh, M.D., M.P.H.
Professor of OphthalmologyDirector, Glaucoma Service
Stanford University
Glaucoma Patients by Region
0
20
40
60
80
100
120
140
160
2015 2020
Nu
mb
er o
f Gla
uco
ma
Pa
tien
ts (m
illio
ns)
Rest of World
Latin America
India
China
Other Wealthy
Nations
Japan
Western Europe
United States
Courtesy of Dave Harmon Market Scope
Glaucoma by Disease Category
Open Angle
42%
Closed
Angle
15%
Secondary
7%
OcularHypertension36%
125 Million
Courtesy of Dave Harmon Market Scope
Courtesy of Dr. Cynthia Mattox
Glaucoma Prevalence by Age
Prevent Blindness America Future of Vision Report 2014Courtesy of Dr. Cynthia Mattox
Glaucoma: The Big Picture
25-50% aware that they have disease* Those aware are often not under care Those under care are often non compliant Unpredictable natural history of disease Small percentage go blind Lowering IOP reduces but does not eliminate
risk
*Sommer A, et al. Arch Ophthalmol. 1991;109:1990-95.
U.S. Ophthalmologists
Specialty
41%
Courtesy of Dr. Gregory Skuta and AAO Member Services
Comprehensive with Specialty
19%
Comprehensive 40%
U.S. Specialty Breakdown
Retina/Vitreous29%
Cornea and External Disease
18%
Pediatrics and Strabismus
14%
Oculoplastics and Orbit
12%
Cataract/Anterior Segment
8%
Other 3%
Neuro2%
Refractive Surgery
1%
Uveitis1%
Glaucoma12%
Courtesy of Dr. Gregory Skuta and AAO Member Services
Global Glaucoma Pharmaceutical Market Revenues by Category
Branded
Prostaglandin28%
Generic Prostaglandin
7%
Beta Blockers…
Carbonic Anhydrase
Inhibitors11%
Alpha Agonists
11%
Fixed Combo
Drugs37%
Other
2%
$4.7 Billion in 2015
Courtesy of Dave Harmon Market Scope
Surgical Trends: 1994-2012
020000400006000080000
100000120000140000160000180000200000
Trabec
Tube
CPC
LTP
LPI
Courtesy of Drs. William Rich, Michael Repka and Gregory Skuta
0
50
100
150
200
250
300
2013 2014 2019 (Forecast)
64
64 62
44
46 5
4
20 4
2
25
5
US
Gla
uco
ma
Su
rger
ies
(000
)
Filtration Tube Shunts MIGS
U.S. Glaucoma Surgical Procedures
Courtesy of Dave Harmon Market Scope
Spotlight on Pressure Reduction: Addressing Unmet Needs in Glaucoma Care
More effective first line and adjunctive medications Glaucoma operation safer than trabeculectomyNovel drug delivery to improve compliance
SPOTLIGHT ON PRESSURE REDUCTION
Company Presentations